-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for ulcerative colitis
Byron P Vaughn, Alan C Moss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation